Optimal Enrollment in Late-Stage New Drug Development with Learning of Drug's Efficacy for Group-Sequential Clinical Trials.
Saved in:
| Title: | Optimal Enrollment in Late-Stage New Drug Development with Learning of Drug's Efficacy for Group-Sequential Clinical Trials. |
|---|---|
| Authors: | Tian, Zhili1 (AUTHOR) zhili.a.tian@gmail.com, Hazen, Gordon B.2 (AUTHOR) GBH305@northwestern.edu, Li, Hong3 (AUTHOR) hogli@ucdavis.edu |
| Source: | Manufacturing & Service Operations Management (M&SOM) (INFORMS). Jan/Feb2023, Vol. 25 Issue 1, p88-107. 20p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15234614 |
|---|---|
| DOI: | 10.1287/msom.2022.1162 |
